<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Precision Clinical Health Analysis — Example Report — N1 Healthcare</title>
  <link rel="icon" type="image/png" href="../images/favicon.png">
  <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
  <script src="https://cdn.jsdelivr.net/npm/chartjs-plugin-annotation"></script>
  <script>
    if (window['chartjs-plugin-annotation']) {
      Chart.register(window['chartjs-plugin-annotation']);
    }
  </script>
  <style>
    /* ==========================================================
       Comprehensive Health Report - Professional Medical Design
       ========================================================== */

    :root {
      --brand: #0d7377;
      --brand-light: #F0FDFA;
      --brand-dark: #094F52;
      --red: #DC2626;
      --red-bg: #FEF2F2;
      --amber: #D97706;
      --amber-bg: #FFFBEB;
      --green: #16A34A;
      --green-bg: #F0FDF4;
      --text: #0f172a;
      --text-secondary: #334155;
      --text-muted: #475569;
      --bg: #F8FAFC;
      --white: #FFFFFF;
      --border: #CBD5E1;
      --border-light: #F1F5F9;
      --radius: 8px;
    }

    * { margin: 0; padding: 0; box-sizing: border-box; }

    body {
      font-family: 'Inter', -apple-system, BlinkMacSystemFont, 'Segoe UI', system-ui, sans-serif;
      background: var(--bg);
      color: var(--text);
      line-height: 1.65;
      font-size: 15px;
      -webkit-font-smoothing: antialiased;
    }

    .report {
      max-width: 1100px;
      margin: 0 auto;
      background: var(--white);
      box-shadow: 0 1px 3px rgba(0,0,0,0.08), 0 8px 32px rgba(0,0,0,0.06);
    }

    /* Header */
    .header {
      background: var(--brand);
      color: var(--white);
      padding: 24px 32px;
      display: flex;
      justify-content: space-between;
      align-items: center;
    }

    .header-title h1 {
      font-size: 1.75rem;
      font-weight: 700;
      margin-bottom: 4px;
    }

    .header-title p {
      opacity: 0.9;
      font-size: 0.95rem;
    }

    .header-right {
      text-align: right;
      display: flex;
      align-items: center;
      gap: 20px;
    }

    .header-logo {
      height: 48px;
      width: auto;
    }

    .header-date {
      font-size: 0.9rem;
      opacity: 0.9;
    }

    /* Patient Bar */
    .patient-bar {
      background: var(--border-light);
      padding: 16px 32px;
      display: flex;
      gap: 48px;
      border-bottom: 1px solid var(--border);
    }

    .patient-bar .field {
      display: flex;
      flex-direction: column;
    }

    .field-label {
      font-size: 0.75rem;
      text-transform: uppercase;
      letter-spacing: 0.05em;
      color: var(--text-muted);
      margin-bottom: 2px;
    }

    .field-value {
      font-weight: 600;
      color: var(--text);
    }

    /* Alert Strip */
    .alert-strip {
      background: var(--red-bg);
      border-left: 4px solid var(--red);
      padding: 16px 32px;
      display: flex;
      align-items: flex-start;
      gap: 12px;
    }

    .alert-strip-icon {
      font-size: 1.5rem;
    }

    .alert-strip-content h3 {
      color: var(--red);
      font-size: 1rem;
      font-weight: 700;
      margin-bottom: 8px;
    }

    .alert-strip-content ul {
      margin: 0;
      padding-left: 20px;
      color: var(--text);
    }

    .alert-strip-content li {
      margin-bottom: 4px;
    }

    /* Content */
    .content {
      padding: 32px;
    }

    /* Section */
    .section {
      margin-bottom: 40px;
    }

    .section-title {
      font-size: 1.25rem;
      font-weight: 700;
      color: var(--brand);
      margin-bottom: 20px;
      padding-bottom: 10px;
      border-bottom: 2px solid var(--brand-light);
      display: flex;
      align-items: center;
      gap: 10px;
    }

    .section-title .icon {
      font-size: 1.2rem;
    }

    /* Collapsible Sections */
    .collapsible {
      cursor: pointer;
      user-select: none;
    }

    .collapsible::after {
      content: ' [+]';
      font-size: 0.9rem;
      color: var(--text-muted);
    }

    .collapsible.active::after {
      content: ' [-]';
    }

    .collapsible-content {
      display: none;
      padding-top: 16px;
    }

    .collapsible-content.show {
      display: block;
    }

    /* SBAR Cards */
    .actions-grid {
      display: grid;
      grid-template-columns: repeat(2, 1fr);
      gap: 16px;
    }

    .action-card {
      background: var(--white);
      border: 1px solid var(--border);
      border-radius: var(--radius);
      overflow: hidden;
    }

    .action-card-header {
      padding: 12px 16px;
      font-weight: 600;
      display: flex;
      align-items: center;
      gap: 10px;
      font-size: 0.95rem;
    }

    .action-card-header .dot {
      width: 10px;
      height: 10px;
      border-radius: 50%;
    }

    .action-card-header .dot.red { background: var(--red); }
    .action-card-header .dot.amber { background: var(--amber); }
    .action-card-header .dot.green { background: var(--green); }
    .action-card-header .dot.brand { background: var(--brand); }

    .action-card-body {
      padding: 12px 16px;
      background: var(--bg);
    }

    .action-card-body ul {
      margin: 0;
      padding-left: 18px;
    }

    .action-card-body li {
      margin-bottom: 6px;
      font-size: 0.9rem;
    }

    /* At-a-Glance Cards */
    .at-a-glance {
      display: grid;
      grid-template-columns: repeat(auto-fit, minmax(180px, 1fr));
      gap: 16px;
    }

    .glance-card {
      background: var(--white);
      border: 1px solid var(--border);
      border-radius: var(--radius);
      padding: 16px;
      text-align: center;
    }

    .glance-label {
      font-size: 0.8rem;
      text-transform: uppercase;
      letter-spacing: 0.05em;
      color: var(--text-muted);
      margin-bottom: 8px;
    }

    .glance-value {
      font-size: 1.75rem;
      font-weight: 700;
    }

    .glance-value.status-red { color: var(--red); }
    .glance-value.status-amber { color: var(--amber); }
    .glance-value.status-green { color: var(--green); }

    .glance-context {
      font-size: 0.8rem;
      color: var(--text-muted);
      margin-top: 4px;
    }

    /* Summary Text */
    .summary-text {
      line-height: 1.8;
      color: var(--text-secondary);
    }

    .summary-text p {
      margin-bottom: 16px;
    }

    .summary-text strong {
      color: var(--text);
    }

    /* Findings List */
    .findings-list {
      display: flex;
      flex-direction: column;
      gap: 20px;
    }

    .finding {
      background: var(--white);
      border: 1px solid var(--border);
      border-radius: var(--radius);
      overflow: hidden;
    }

    .finding.priority-high {
      border-left: 4px solid var(--red);
    }

    .finding.priority-medium {
      border-left: 4px solid var(--amber);
    }

    .finding.priority-low {
      border-left: 4px solid var(--green);
    }

    .finding-header {
      padding: 16px;
      background: var(--bg);
      display: flex;
      justify-content: space-between;
      align-items: center;
      cursor: pointer;
    }

    .finding-title {
      font-weight: 600;
      font-size: 1.05rem;
    }

    .finding-tag {
      padding: 4px 10px;
      border-radius: 12px;
      font-size: 0.75rem;
      font-weight: 600;
      text-transform: uppercase;
    }

    .tag-critical { background: var(--red-bg); color: var(--red); }
    .tag-warning { background: var(--amber-bg); color: var(--amber); }
    .tag-moderate { background: var(--green-bg); color: var(--green); }
    .tag-info { background: var(--brand-light); color: var(--brand); }

    .finding-body {
      padding: 16px;
    }

    .finding-body p {
      margin-bottom: 12px;
      color: var(--text-secondary);
    }

    /* Data Tables */
    .data-table {
      width: 100%;
      border-collapse: collapse;
      font-size: 0.9rem;
      margin: 16px 0;
    }

    .data-table th,
    .data-table td {
      padding: 10px 12px;
      text-align: left;
      border-bottom: 1px solid var(--border-light);
    }

    .data-table th {
      background: var(--bg);
      font-weight: 600;
      color: var(--text-muted);
      text-transform: uppercase;
      font-size: 0.75rem;
      letter-spacing: 0.05em;
    }

    .data-table .row-critical { background: var(--red-bg); }
    .data-table .row-warning { background: var(--amber-bg); }
    .data-table .row-ok { background: var(--green-bg); }

    .data-table .value-col { text-align: center; font-weight: 600; }
    .data-table .ref-col { color: var(--text-muted); }
    .data-table .status-cell { text-align: center; }

    /* Timeline */
    .timeline {
      position: relative;
      padding-left: 30px;
    }

    .timeline::before {
      content: '';
      position: absolute;
      left: 8px;
      top: 0;
      bottom: 0;
      width: 2px;
      background: var(--border);
    }

    .tl-item {
      position: relative;
      padding-bottom: 24px;
    }

    .tl-dot {
      position: absolute;
      left: -26px;
      top: 4px;
      width: 12px;
      height: 12px;
      border-radius: 50%;
      border: 2px solid var(--white);
      box-shadow: 0 0 0 2px var(--border);
    }

    .tl-dot.tl-red { background: var(--red); box-shadow: 0 0 0 2px var(--red); }
    .tl-dot.tl-amber { background: var(--amber); box-shadow: 0 0 0 2px var(--amber); }
    .tl-dot.tl-green { background: var(--green); box-shadow: 0 0 0 2px var(--green); }

    .tl-date {
      font-size: 0.8rem;
      color: var(--text-muted);
      margin-bottom: 4px;
    }

    .tl-content {
      background: var(--bg);
      padding: 12px 16px;
      border-radius: var(--radius);
    }

    .tl-name {
      font-weight: 600;
      margin-bottom: 4px;
    }

    .tl-change {
      font-size: 0.9rem;
      color: var(--text-secondary);
    }

    /* Chart Container */
    .chart-container {
      background: var(--white);
      border: 1px solid var(--border);
      border-radius: var(--radius);
      padding: 20px;
      margin: 20px 0;
    }

    .chart-container h3 {
      font-size: 1rem;
      font-weight: 600;
      margin-bottom: 16px;
      color: var(--text);
    }

    .chart-row {
      display: grid;
      grid-template-columns: repeat(2, 1fr);
      gap: 20px;
    }

    .trend-chart {
      height: 280px;
      position: relative;
    }

    .trend-insight {
      padding: 12px 16px;
      border-radius: var(--radius);
      font-size: 0.9rem;
      margin-top: 12px;
    }

    .trend-insight.improving { background: var(--green-bg); color: var(--green); }
    .trend-insight.declining { background: var(--red-bg); color: var(--red); }
    .trend-insight.stable { background: var(--amber-bg); color: var(--amber); }

    /* Hypothesis Card */
    .hypothesis-card {
      background: var(--bg);
      border: 1px solid var(--border);
      border-radius: var(--radius);
      padding: 16px;
      display: flex;
      justify-content: space-between;
      align-items: flex-start;
      gap: 16px;
      margin: 16px 0;
    }

    .hypothesis-card h4 {
      font-size: 1rem;
      margin-bottom: 8px;
    }

    .hypothesis-reasoning {
      font-size: 0.9rem;
      color: var(--text-secondary);
    }

    .certainty-badge {
      padding: 6px 12px;
      border-radius: 16px;
      font-size: 0.75rem;
      font-weight: 700;
      text-transform: uppercase;
      white-space: nowrap;
    }

    .certainty-badge.confirmed { background: var(--green); color: white; }
    .certainty-badge.probable { background: var(--brand); color: white; }
    .certainty-badge.possible { background: var(--amber); color: white; }
    .certainty-badge.unlikely { background: var(--text-muted); color: white; }
    .certainty-badge.ruled-out { background: var(--red); color: white; }

    /* Verification Box */
    .verification-box {
      background: var(--brand-light);
      border: 1px solid var(--brand);
      border-radius: var(--radius);
      padding: 20px;
      margin: 20px 0;
    }

    .verification-box h4 {
      font-size: 1rem;
      color: var(--brand-dark);
      margin-bottom: 16px;
    }

    .verify-grid {
      display: grid;
      grid-template-columns: repeat(2, 1fr);
      gap: 20px;
    }

    .verify-col h5 {
      font-size: 0.85rem;
      margin-bottom: 8px;
    }

    .verify-col.verify-confirm h5 { color: var(--green); }
    .verify-col.verify-refute h5 { color: var(--red); }

    .verify-col ul {
      font-size: 0.9rem;
      padding-left: 18px;
      color: var(--text-secondary);
    }

    .verify-col li {
      margin-bottom: 6px;
    }

    /* Evidence Badge */
    .evidence-badge {
      padding: 3px 8px;
      border-radius: 10px;
      font-size: 0.7rem;
      font-weight: 600;
      text-transform: uppercase;
      margin-left: 8px;
    }

    .evidence-badge.evidence-strong { background: var(--green-bg); color: var(--green); }
    .evidence-badge.evidence-moderate { background: var(--brand-light); color: var(--brand); }
    .evidence-badge.evidence-limited { background: var(--amber-bg); color: var(--amber); }
    .evidence-badge.evidence-weak { background: var(--red-bg); color: var(--red); }

    /* Data Badge */
    .data-badge {
      padding: 2px 6px;
      border-radius: 8px;
      font-size: 0.65rem;
      font-weight: 600;
      text-transform: uppercase;
      margin-left: 6px;
    }

    .data-badge.current { background: var(--green-bg); color: var(--green); }
    .data-badge.recent { background: var(--brand-light); color: var(--brand); }
    .data-badge.historical { background: var(--amber-bg); color: var(--amber); }

    /* Root Cause Visual */
    .root-cause-visual {
      display: flex;
      flex-direction: column;
      align-items: center;
      padding: 30px;
      background: var(--bg);
      border-radius: var(--radius);
      margin: 20px 0;
    }

    .root-cause-hub {
      background: var(--red);
      color: var(--white);
      padding: 20px 30px;
      border-radius: var(--radius);
      font-weight: 700;
      font-size: 1.1rem;
      text-align: center;
      margin-bottom: 30px;
    }

    .root-cause-spokes {
      display: grid;
      grid-template-columns: repeat(3, 1fr);
      gap: 20px;
      width: 100%;
    }

    .spoke {
      background: var(--white);
      border: 1px solid var(--border);
      border-radius: var(--radius);
      padding: 16px;
    }

    .spoke-title {
      font-weight: 600;
      font-size: 0.9rem;
      color: var(--brand);
      margin-bottom: 8px;
    }

    .spoke-body {
      font-size: 0.85rem;
      color: var(--text-secondary);
    }

    /* Heatmap */
    .heatmap-wrap {
      overflow-x: auto;
      margin: 20px 0;
    }

    .heatmap-grid {
      display: grid;
      gap: 2px;
      font-size: 0.75rem;
    }

    .heatmap-cell {
      padding: 8px;
      text-align: center;
      border-radius: 4px;
      min-width: 60px;
    }

    .heatmap-cell.pos-strong { background: #166534; color: white; }
    .heatmap-cell.pos-moderate { background: #22C55E; color: white; }
    .heatmap-cell.pos-weak { background: #BBF7D0; color: #166534; }
    .heatmap-cell.neutral { background: var(--border-light); color: var(--text-muted); }
    .heatmap-cell.neg-weak { background: #FED7AA; color: #9A3412; }
    .heatmap-cell.neg-moderate { background: #F97316; color: white; }
    .heatmap-cell.neg-strong { background: #DC2626; color: white; }

    .heatmap-label {
      font-weight: 600;
      background: var(--bg);
      color: var(--text);
    }

    /* Prognosis Bar */
    .prognosis-bar-container {
      margin: 20px 0;
    }

    .prognosis-bar {
      height: 24px;
      background: linear-gradient(90deg, var(--red), var(--amber), var(--green));
      border-radius: 12px;
      position: relative;
    }

    .prognosis-marker {
      position: absolute;
      top: -8px;
      width: 4px;
      height: 40px;
      background: var(--text);
      border-radius: 2px;
      transform: translateX(-50%);
    }

    .prognosis-labels {
      display: flex;
      justify-content: space-between;
      margin-top: 8px;
      font-size: 0.8rem;
      color: var(--text-muted);
    }

    /* Longevity Disclaimer */
    .longevity-disclaimer {
      background: var(--amber-bg);
      border: 1px solid var(--amber);
      border-radius: var(--radius);
      padding: 20px;
      margin: 20px 0;
    }

    .longevity-disclaimer h4 {
      color: var(--amber);
      margin-bottom: 12px;
    }

    .disclaimer-details {
      font-size: 0.9rem;
      margin: 12px 0;
    }

    .disclaimer-details td {
      padding: 4px 12px 4px 0;
    }

    .improvement-path {
      background: var(--white);
      padding: 12px;
      border-radius: var(--radius);
      margin-top: 12px;
      font-size: 0.9rem;
    }

    /* Schedule Table */
    .schedule-table {
      width: 100%;
      border-collapse: collapse;
      margin: 16px 0;
    }

    .schedule-table th,
    .schedule-table td {
      padding: 12px;
      border-bottom: 1px solid var(--border-light);
      text-align: left;
    }

    .schedule-table th {
      background: var(--brand);
      color: var(--white);
      font-weight: 600;
    }

    .schedule-table .time-col {
      font-weight: 600;
      width: 150px;
    }

    .schedule-table .notes-col {
      color: var(--text-muted);
      font-size: 0.9rem;
    }

    /* Follow-up Grid */
    .followup-grid {
      display: grid;
      grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
      gap: 16px;
    }

    .followup-item {
      background: var(--bg);
      border: 1px solid var(--border);
      border-radius: var(--radius);
      padding: 16px;
    }

    .followup-item h4 {
      font-size: 1rem;
      margin-bottom: 8px;
    }

    .followup-when {
      color: var(--brand);
      font-weight: 600;
      font-size: 0.85rem;
      margin-bottom: 8px;
    }

    .followup-item p {
      font-size: 0.9rem;
      color: var(--text-secondary);
    }

    /* Reference List */
    .reference-list {
      font-size: 0.85rem;
      color: var(--text-secondary);
      padding-left: 24px;
    }

    .reference-list li {
      margin-bottom: 10px;
    }

    .reference-list a {
      color: var(--brand);
      text-decoration: none;
    }

    .reference-list a:hover {
      text-decoration: underline;
    }

    .reference-list li:target {
      background: var(--amber-bg);
      padding: 4px 8px;
      margin: -4px -8px;
      border-radius: 4px;
    }

    /* Callout */
    .callout {
      padding: 16px;
      border-radius: var(--radius);
      margin: 16px 0;
      background: var(--brand-light);
      border-left: 4px solid var(--brand);
    }

    .callout.callout-amber {
      background: var(--amber-bg);
      border-left-color: var(--amber);
    }

    .callout.callout-red {
      background: var(--red-bg);
      border-left-color: var(--red);
    }

    .callout.callout-green {
      background: var(--green-bg);
      border-left-color: var(--green);
    }

    .callout strong {
      display: block;
      margin-bottom: 8px;
    }

    /* Evidence Block */
    .evidence-block {
      background: var(--white);
      border: 1px solid var(--border);
      border-radius: var(--radius);
      padding: 16px;
      margin: 12px 0;
      font-style: italic;
    }

    .evidence-block cite {
      display: block;
      margin-top: 8px;
      font-style: normal;
      font-size: 0.85rem;
      color: var(--text-muted);
    }

    /* Contested Claims */
    .contested-claim {
      background: linear-gradient(135deg, #fef3c7 0%, #fde68a 100%);
      border: 2px solid #f59e0b;
      border-radius: 12px;
      padding: 20px;
      margin: 20px 0;
    }

    .contested-claim h4 {
      color: #92400e;
      margin-bottom: 15px;
    }

    .claim-evidence {
      display: grid;
      grid-template-columns: 1fr 1fr;
      gap: 15px;
      margin: 15px 0;
    }

    .claim-evidence .supporting {
      background: white;
      padding: 15px;
      border-radius: 8px;
      border-left: 4px solid #38a169;
    }

    .claim-evidence .contradicting {
      background: white;
      padding: 15px;
      border-radius: 8px;
      border-left: 4px solid #c53030;
    }

    .interpretation {
      background: white;
      padding: 15px;
      border-radius: 8px;
      margin-top: 15px;
    }

    /* Data Gaps */
    .data-gaps {
      background: var(--amber-bg);
      border: 1px solid var(--amber);
      border-radius: var(--radius);
      padding: 20px;
      margin: 20px 0;
    }

    .data-gaps h3 {
      color: var(--amber);
      margin-bottom: 16px;
    }

    .data-gaps-grid {
      display: grid;
      grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
      gap: 16px;
    }

    .gap-card {
      background: var(--white);
      padding: 16px;
      border-radius: var(--radius);
    }

    .gap-card h4 {
      font-size: 1rem;
      margin-bottom: 8px;
    }

    .gap-card p {
      font-size: 0.9rem;
      color: var(--text-secondary);
      margin-bottom: 6px;
    }

    /* Disclaimer */
    .report-disclaimer {
      background: var(--bg);
      border: 1px solid var(--border);
      border-radius: var(--radius);
      padding: 24px;
      margin: 40px 0 20px;
      font-size: 0.85rem;
      color: var(--text-secondary);
    }

    .report-disclaimer h3 {
      color: var(--text);
      margin-bottom: 12px;
    }

    /* Footer */
    .report-footer {
      background: var(--brand);
      color: var(--white);
      padding: 20px 32px;
      text-align: center;
      font-size: 0.9rem;
    }

    .report-footer a {
      color: var(--white);
      text-decoration: underline;
    }

    /* Responsive */
    @media (max-width: 768px) {
      .header {
        flex-direction: column;
        text-align: center;
        gap: 16px;
      }

      .header-right {
        flex-direction: column;
      }

      .patient-bar {
        flex-wrap: wrap;
        gap: 24px;
      }

      .actions-grid {
        grid-template-columns: 1fr;
      }

      .chart-row {
        grid-template-columns: 1fr;
      }

      .root-cause-spokes {
        grid-template-columns: 1fr;
      }

      .verify-grid {
        grid-template-columns: 1fr;
      }
    }

    /* Print */
    @media print {
      .report {
        box-shadow: none;
      }

      .collapsible-content {
        display: block !important;
      }

      .collapsible::after {
        display: none;
      }

      .header {
        background: var(--brand) !important;
        -webkit-print-color-adjust: exact;
        print-color-adjust: exact;
      }
    }
  </style>
</head>
<body>
  <div class="report">
    <!-- Header -->
    <header class="header">
      <div class="header-title">
        <h1>Comprehensive Health Report</h1>
        <p>Longitudinal Analysis & Clinical Recommendations</p>
      </div>
      <div class="header-right">
        <img class="header-logo" src="data:image/png;base64,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" alt="n1.care logo">
        <div class="header-date">Report Date: February 15, 2026</div>
      </div>
    </header>

    <!-- Critical Alert Strip -->
    <div class="alert-strip">
      <span class="alert-strip-icon">&#9888;</span>
      <div class="alert-strip-content">
        <h3>Critical Findings Requiring Immediate Attention</h3>
        <ul>
          <li><strong>Rapid Ferritin Decline:</strong> Dropped from 101 to 19 ug/L in 12 months - below reference range, suggesting ongoing blood loss</li>
          <li><strong>Severe Adrenal Exhaustion:</strong> Severity 8/10 - HPA axis dysfunction with depleted catecholamine reserve</li>
          <li><strong>Hidden Insulin Resistance:</strong> Fasting insulin 28-30 uIU/mL (5x elevated) despite normal glucose/HbA1c</li>
          <li><strong>Active Chronic Infections:</strong> Mycoplasma and Schistosoma with immune exhaustion pattern (CD57: 70/uL)</li>
        </ul>
      </div>
    </div>

    <!-- Patient Bar -->
    <div class="patient-bar">
      <div class="field">
        <span class="field-label">Patient ID</span>
        <span class="field-value">John Doe</span>
      </div>
      <div class="field">
        <span class="field-label">Gender</span>
        <span class="field-value">Unknown</span>
      </div>
      <div class="field">
        <span class="field-label">Records Period</span>
        <span class="field-value">2015 - 2025</span>
      </div>
      <div class="field">
        <span class="field-label">Data Points</span>
        <span class="field-value">7,331 biomarkers, 65 diagnoses</span>
      </div>
      <div class="field">
        <span class="field-label">Analysis Date</span>
        <span class="field-value">February 15, 2026</span>
      </div>
    </div>

    <div class="content">
      <!-- SBAR Clinical Summary -->
      <section class="section">
        <h2 class="section-title"><span class="icon">&#128203;</span> SBAR Clinical Summary</h2>
        <div class="actions-grid">
          <div class="action-card">
            <div class="action-card-header">
              <span class="dot red"></span>
              Situation
            </div>
            <div class="action-card-body">
              <ul>
                <li>Multi-system dysfunction with accelerated biological aging (+3.5 years)</li>
                <li>Ferritin crisis: 101 to 19 ug/L in 12 months</li>
                <li>Severe adrenal medulla exhaustion (Severity 8/10)</li>
                <li>Active intracellular infections driving immune exhaustion</li>
              </ul>
            </div>
          </div>
          <div class="action-card">
            <div class="action-card-header">
              <span class="dot amber"></span>
              Background
            </div>
            <div class="action-card-body">
              <ul>
                <li>10-year longitudinal health data available</li>
                <li>GI disease: gastritis, colitis (July 2024), hemorrhoidectomy</li>
                <li>Documented infections: Mycoplasma, Schistosoma</li>
                <li>Genetic vulnerabilities: GPX1 AG (reduced antioxidant), CBS risk variant</li>
              </ul>
            </div>
          </div>
          <div class="action-card">
            <div class="action-card-header">
              <span class="dot green"></span>
              Assessment
            </div>
            <div class="action-card-body">
              <ul>
                <li><strong>Root Cause:</strong> Chronic infection-driven allostatic overload</li>
                <li>HPA-immune-metabolic dysfunction triad</li>
                <li>NAD+ depletion (15.2 nmol/ml) causing cellular energy crisis</li>
                <li>Inflammation-driven cardiovascular risk (D-dimer 570 ng/mL)</li>
              </ul>
            </div>
          </div>
          <div class="action-card">
            <div class="action-card-header">
              <span class="dot brand"></span>
              Recommendation
            </div>
            <div class="action-card-body">
              <ul>
                <li><strong>URGENT:</strong> GI evaluation for blood loss source</li>
                <li>Infectious disease consultation for antimicrobial therapy</li>
                <li>GLP-1 agonist (semaglutide) for metabolic dysfunction</li>
                <li>DHEA 25-50mg + NAD+ precursor (NR 300mg)</li>
              </ul>
            </div>
          </div>
        </div>
      </section>

      <!-- Key Metrics Dashboard -->
      <section class="section">
        <h2 class="section-title"><span class="icon">&#128200;</span> Key Metrics Dashboard</h2>
        <div class="at-a-glance">
          <div class="glance-card">
            <div class="glance-label">Ferritin</div>
            <div class="glance-value status-red">19</div>
            <div class="glance-context">ug/L (ref 22-322)</div>
          </div>
          <div class="glance-card">
            <div class="glance-label">Fasting Insulin</div>
            <div class="glance-value status-red">28.3</div>
            <div class="glance-context">uIU/mL (ref 3-25)</div>
          </div>
          <div class="glance-card">
            <div class="glance-label">NAD+</div>
            <div class="glance-value status-red">15.2</div>
            <div class="glance-context">nmol/ml (ref 20-42)</div>
          </div>
          <div class="glance-card">
            <div class="glance-label">D-Dimer</div>
            <div class="glance-value status-amber">570</div>
            <div class="glance-context">ng/mL (ref &lt;500)</div>
          </div>
          <div class="glance-card">
            <div class="glance-label">CD57 NK Cells</div>
            <div class="glance-value status-amber">70</div>
            <div class="glance-context">/uL (ref 60-360)</div>
          </div>
          <div class="glance-card">
            <div class="glance-label">HbA1c</div>
            <div class="glance-value status-green">5.6%</div>
            <div class="glance-context">(ref &lt;5.7%)</div>
          </div>
        </div>
      </section>

      <!-- Executive Summary -->
      <section class="section">
        <h2 class="section-title"><span class="icon">&#128196;</span> Executive Summary</h2>
        <div class="summary-text">
          <p>This report analyzes <strong>7,331 biomarker measurements</strong> across multiple body systems, <strong>65 diagnoses</strong>, and <strong>1,644 genetic variants</strong>, spanning a 10-year period from September 2015 to November 2025. The analysis reveals a complex, interconnected pattern of dysfunction with evidence of accelerated biological aging.</p>

          <p>The clinical picture is dominated by <strong>four confirmed conditions forming a self-reinforcing cycle of deterioration</strong>: (1) HPA Axis Dysfunction with severe adrenal exhaustion (Severity 8/10), characterized by depleted DHEA and elevated cortisol:DHEA ratio of 7.2; (2) Chronic Immune Suppression with active Mycoplasma and Schistosoma infections, showing paradoxical immune hyperactivation (NK cells 250/uL) alongside exhaustion (CD57 70/uL, CD8+CD28- senescent cells at 58%); (3) Metabolic Syndrome with "hidden" insulin resistance - fasting insulin elevated to 28-30 uIU/mL despite normal glucose and HbA1c; and (4) Cardiovascular Risk from chronic inflammation with volatile D-dimer (270-570 ng/mL).</p>

          <p>The most urgent finding is a <strong>rapid ferritin decline from 101 to 19 ug/L</strong> over 12 months, now below reference range. Combined with documented gastritis, colitis, and recent hemorrhoidectomy, this strongly suggests ongoing GI blood loss requiring immediate investigation. Additionally, <strong>NAD+ depletion at 15.2 nmol/ml</strong> (24% below lower limit) indicates mitochondrial energy crisis, explaining fatigue and contributing to accelerated biological aging (+3.5 years epigenetic age). The root cause analysis points to chronic intracellular infections as the primary driver, creating sustained immune activation that has exhausted HPA axis reserve, impaired immune clearance, and driven metabolic dysfunction in a vicious cycle.</p>
        </div>
      </section>

      <!-- Health Storylines -->
      <section class="section">
        <h2 class="section-title"><span class="icon">&#128218;</span> Health Storylines</h2>

        <div class="findings-list">
          <!-- Story 1: HPA Axis -->
          <div class="finding priority-high">
            <div class="finding-header collapsible" onclick="toggleSection(this)">
              <span class="finding-title">1. HPA Axis Exhaustion and Adrenal Insufficiency</span>
              <span class="finding-tag tag-critical">Confirmed - Severity 8/10</span>
            </div>
            <div class="finding-body collapsible-content show">
              <div class="hypothesis-card">
                <div>
                  <h4>Assessment Classification</h4>
                  <div class="hypothesis-reasoning">
                    <p><strong>Based on:</strong> Multiple cortisol measurements, documented DHEA deficiency (Nov 2024), and severe adrenal medulla exhaustion diagnosis (July 2025). Cortisol:DHEA ratio of 7.2 (elevated &gt;5.0) confirms chronic stress adaptation pattern.</p>
                  </div>
                </div>
                <span class="certainty-badge confirmed">CONFIRMED</span>
              </div>

              <p>The patient demonstrates classic HPA axis exhaustion with a characteristic pattern: elevated cortisol:DHEA ratio indicating prioritization of cortisol at the expense of DHEA, blunted diurnal cortisol rhythm, and documented norepinephrine deficiency indicating depleted catecholamine reserve. This serves as a central hub connecting immune suppression, metabolic dysfunction, and accelerated aging.<sup><a href="#ref-1">[1]</a></sup><sup><a href="#ref-28">[28]</a></sup></p>

              <table class="data-table">
                <thead>
                  <tr>
                    <th>Marker</th>
                    <th class="value-col">Value</th>
                    <th>Date</th>
                    <th class="ref-col">Reference</th>
                    <th class="status-cell">Status</th>
                  </tr>
                </thead>
                <tbody>
                  <tr class="row-warning">
                    <td>Cortisol (morning)</td>
                    <td class="value-col">201 nmol/L</td>
                    <td>Nov 2025</td>
                    <td class="ref-col">146-621</td>
                    <td class="status-cell"><span class="finding-tag tag-warning">Low-Normal</span></td>
                  </tr>
                  <tr class="row-critical">
                    <td>Cortisol:DHEA Ratio</td>
                    <td class="value-col">7.2</td>
                    <td>Sept 2024</td>
                    <td class="ref-col">&lt;5.0</td>
                    <td class="status-cell"><span class="finding-tag tag-critical">Elevated</span></td>
                  </tr>
                  <tr class="row-critical">
                    <td>Free Cortisol (2nd AM)</td>
                    <td class="value-col">94.69 ug/g Cr</td>
                    <td>July 2025</td>
                    <td class="ref-col">23.4-68.9</td>
                    <td class="status-cell"><span class="finding-tag tag-critical">Elevated</span></td>
                  </tr>
                  <tr class="row-warning">
                    <td>DHEA</td>
                    <td class="value-col">Low</td>
                    <td>May 2024</td>
                    <td class="ref-col">Normal</td>
                    <td class="status-cell"><span class="finding-tag tag-warning">Deficient</span></td>
                  </tr>
                </tbody>
              </table>

              <div class="evidence-block">
                <p>"Elevated cortisol/DHEA ratios in chronic infection correlate with impaired immune control. HPA axis activation contributes to disease progression by impairing protective immune responses."</p>
                <cite>PMC Article PMC12880830 (2024)<sup><a href="#ref-2">[2]</a></sup> <span class="evidence-badge evidence-moderate">Moderate</span></cite>
              </div>

              <div class="verification-box">
                <h4>Verification Guidance</h4>
                <div class="verify-grid">
                  <div class="verify-col verify-confirm">
                    <h5>What Would Increase Confidence</h5>
                    <ul>
                      <li>DHEA-S levels to confirm deficiency severity</li>
                      <li>4-point salivary cortisol to map diurnal rhythm</li>
                      <li>ACTH stimulation test if secondary insufficiency suspected</li>
                    </ul>
                  </div>
                  <div class="verify-col verify-refute">
                    <h5>What Would Refute This</h5>
                    <ul>
                      <li>Normal cortisol:DHEA ratio on repeat testing</li>
                      <li>Normal catecholamine levels</li>
                      <li>Resolution of symptoms without HPA intervention</li>
                    </ul>
                  </div>
                </div>
              </div>
            </div>
          </div>

          <!-- Story 2: Chronic Infections -->
          <div class="finding priority-high">
            <div class="finding-header collapsible" onclick="toggleSection(this)">
              <span class="finding-title">2. Chronic Immune Suppression with Intracellular Infections</span>
              <span class="finding-tag tag-critical">Confirmed - Severity 7/10</span>
            </div>
            <div class="finding-body collapsible-content">
              <div class="hypothesis-card">
                <div>
                  <h4>Assessment Classification</h4>
                  <div class="hypothesis-reasoning">
                    <p><strong>Based on:</strong> Documented Mycoplasma IgA antibodies indicating recent/active infection, Schistosoma antibodies, paradoxical immune pattern with hyperactivation AND exhaustion.</p>
                  </div>
                </div>
                <span class="certainty-badge confirmed">CONFIRMED</span>
              </div>

              <p>The immune system shows simultaneous hyperactivation AND exhaustion - a hallmark of chronic intracellular infection burden. NK cells are expanded to 250/uL (trying to fight pathogens) while CD57+ NK cells are depleted (70/uL - the most cytotoxic subset), CD8+CD28- senescent T cells have expanded to 58%, and CD4:CD8 ratio sits at 7th percentile. This pattern explains why infections persist despite apparent immune activation.<sup><a href="#ref-3">[3]</a></sup></p>

              <table class="data-table">
                <thead>
                  <tr>
                    <th>Marker</th>
                    <th class="value-col">Value</th>
                    <th>Date</th>
                    <th class="ref-col">Reference</th>
                    <th class="status-cell">Status</th>
                  </tr>
                </thead>
                <tbody>
                  <tr class="row-warning">
                    <td>CD57 NK cells</td>
                    <td class="value-col">70/uL</td>
                    <td>July 2025</td>
                    <td class="ref-col">60-360</td>
                    <td class="status-cell"><span class="finding-tag tag-warning">Low</span></td>
                  </tr>
                  <tr class="row-critical">
                    <td>NK Cell Count</td>
                    <td class="value-col">250 cells/uL</td>
                    <td>Nov 2025</td>
                    <td class="ref-col">17-183</td>
                    <td class="status-cell"><span class="finding-tag tag-critical">Elevated</span></td>
                  </tr>
                  <tr class="row-critical">
                    <td>CD8+CD28- (senescent)</td>
                    <td class="value-col">58%</td>
                    <td>July 2025</td>
                    <td class="ref-col">&lt;30%</td>
                    <td class="status-cell"><span class="finding-tag tag-critical">Highly Elevated</span></td>
                  </tr>
                  <tr class="row-warning">
                    <td>CD4:CD8 Ratio</td>
                    <td class="value-col">7th %ile</td>
                    <td>Aug 2025</td>
                    <td class="ref-col">30-80th</td>
                    <td class="status-cell"><span class="finding-tag tag-warning">Abnormal</span></td>
                  </tr>
                </tbody>
              </table>

              <div class="callout callout-amber">
                <strong>Scientific Context: CD57 as Infection Marker</strong>
                <p>The use of CD57 NK cells as a marker for chronic intracellular infections is <strong>contested in the literature</strong>. Stricker & Winger (2001) found decreased CD57 in chronic Lyme patients that improved with treatment, while Marques (2009) found no difference in post-Lyme syndrome vs controls. In this patient, CD57 is relevant because there is <strong>active documented infection</strong> (Mycoplasma), not post-infection syndrome.<sup><a href="#ref-3">[3]</a></sup><sup><a href="#ref-4">[4]</a></sup></p>
              </div>
            </div>
          </div>

          <!-- Story 3: Metabolic Syndrome -->
          <div class="finding priority-high">
            <div class="finding-header collapsible" onclick="toggleSection(this)">
              <span class="finding-title">3. Metabolic Syndrome with Hidden Insulin Resistance</span>
              <span class="finding-tag tag-critical">Confirmed - Highly Actionable</span>
            </div>
            <div class="finding-body collapsible-content">
              <div class="hypothesis-card">
                <div>
                  <h4>Assessment Classification</h4>
                  <div class="hypothesis-reasoning">
                    <p><strong>Based on:</strong> Fasting insulin 28-30 uIU/mL (5x elevated) with normal fasting glucose (4.4 mmol/L) and HbA1c (5.6%). Classic "hidden" pattern - compensatory hyperinsulinemia maintaining glycemic control.</p>
                  </div>
                </div>
                <span class="certainty-badge confirmed">CONFIRMED</span>
              </div>

              <p>This is a <strong>highly actionable finding</strong> that most physicians would miss on routine screening. The patient maintains normal glucose through massively elevated insulin secretion - the pancreas is working overtime.<sup><a href="#ref-24">[24]</a></sup> The 5-fold increase over approximately 12 months indicates rapid progression. Documented fatty liver (NAFLD) compounds metabolic stress. If untreated, progression to overt diabetes is likely within 2-5 years.<sup><a href="#ref-5">[5]</a></sup></p>

              <table class="data-table">
                <thead>
                  <tr>
                    <th>Marker</th>
                    <th class="value-col">Value</th>
                    <th>Date</th>
                    <th class="ref-col">Reference</th>
                    <th class="status-cell">Status</th>
                  </tr>
                </thead>
                <tbody>
                  <tr class="row-critical">
                    <td>Fasting Insulin</td>
                    <td class="value-col">28.3-30.2 uIU/mL</td>
                    <td>Oct 2025</td>
                    <td class="ref-col">3-25</td>
                    <td class="status-cell"><span class="finding-tag tag-critical">Elevated</span></td>
                  </tr>
                  <tr class="row-ok">
                    <td>Fasting Glucose</td>
                    <td class="value-col">4.4 mmol/L</td>
                    <td>Nov 2025</td>
                    <td class="ref-col">3.9-6.0</td>
                    <td class="status-cell"><span class="finding-tag tag-moderate">Normal</span></td>
                  </tr>
                  <tr class="row-ok">
                    <td>HbA1c</td>
                    <td class="value-col">5.6%</td>
                    <td>Nov 2025</td>
                    <td class="ref-col">&lt;5.7%</td>
                    <td class="status-cell"><span class="finding-tag tag-moderate">Normal</span></td>
                  </tr>
                </tbody>
              </table>

              <div class="evidence-block">
                <p>"GLP-1 receptor agonists significantly improve NAFLD histology and insulin sensitivity... Biopsy resolution RR 6.60 vs standard care."</p>
                <cite>Scientific Reports Meta-analysis (2021), 16 RCTs, n=615<sup><a href="#ref-5">[5]</a></sup> <span class="evidence-badge evidence-strong">Strong</span></cite>
              </div>
            </div>
          </div>

          <!-- Story 4: Iron Deficiency -->
          <div class="finding priority-high">
            <div class="finding-header collapsible" onclick="toggleSection(this)">
              <span class="finding-title">4. Iron Deficiency with Rapid Ferritin Decline</span>
              <span class="finding-tag tag-critical">URGENT Investigation Needed</span>
            </div>
            <div class="finding-body collapsible-content">
              <div class="hypothesis-card">
                <div>
                  <h4>Assessment Classification</h4>
                  <div class="hypothesis-reasoning">
                    <p><strong>Based on:</strong> 5-fold ferritin decline (101 to 19 ug/L) over 12 months. Recent hemorrhoidectomy (July 2024), documented gastritis and colitis. Pattern suggests ongoing GI blood loss.</p>
                  </div>
                </div>
                <span class="certainty-badge probable">PROBABLE</span>
              </div>

              <p>The rapid 5-fold decline in ferritin is <strong>clinically significant and requires urgent investigation</strong>.<sup><a href="#ref-25">[25]</a></sup> Most likely cause is GI blood loss given recent hemorrhoidectomy (possible recurrence), documented gastritis/colitis, and low pancreatic elastase (85 vs >200) indicating digestive compromise. Ferritin below 30 ug/L indicates depleted iron stores even with "normal" hemoglobin - this is pre-anemia that will progress.</p>

              <table class="data-table">
                <thead>
                  <tr>
                    <th>Marker</th>
                    <th class="value-col">Value</th>
                    <th>Date</th>
                    <th class="ref-col">Reference</th>
                    <th class="status-cell">Status</th>
                  </tr>
                </thead>
                <tbody>
                  <tr class="row-ok">
                    <td>Ferritin</td>
                    <td class="value-col">101.0 ug/L</td>
                    <td>Dec 2024</td>
                    <td class="ref-col">22-322</td>
                    <td class="status-cell"><span class="finding-tag tag-moderate">Adequate</span></td>
                  </tr>
                  <tr class="row-warning">
                    <td>Ferritin</td>
                    <td class="value-col">36.0 ug/L</td>
                    <td>Mar 2025</td>
                    <td class="ref-col">22-322</td>
                    <td class="status-cell"><span class="finding-tag tag-warning">Low-Normal</span></td>
                  </tr>
                  <tr class="row-critical">
                    <td>Ferritin</td>
                    <td class="value-col">19.0 ug/L</td>
                    <td>Nov 2025</td>
                    <td class="ref-col">22-322</td>
                    <td class="status-cell"><span class="finding-tag tag-critical">Below Range</span></td>
                  </tr>
                  <tr class="row-warning">
                    <td>RBC Count</td>
                    <td class="value-col">4.4 x10^12/L</td>
                    <td>Nov 2025</td>
                    <td class="ref-col">4.5-6.0</td>
                    <td class="status-cell"><span class="finding-tag tag-warning">Low</span></td>
                  </tr>
                </tbody>
              </table>

              <div class="callout callout-red">
                <strong>Urgent Action Required</strong>
                <p>This rate of ferritin decline requires GI evaluation to rule out occult bleeding. Colonoscopy and upper endoscopy recommended if not performed recently. Fecal occult blood test as initial screening. Iron supplementation should begin immediately but will not address underlying cause.</p>
              </div>
            </div>
          </div>

          <!-- Story 5: NAD+ Depletion -->
          <div class="finding priority-high">
            <div class="finding-header collapsible" onclick="toggleSection(this)">
              <span class="finding-title">5. NAD+ Depletion and Accelerated Biological Aging</span>
              <span class="finding-tag tag-critical">Confirmed</span>
            </div>
            <div class="finding-body collapsible-content">
              <div class="hypothesis-card">
                <div>
                  <h4>Assessment Classification</h4>
                  <div class="hypothesis-reasoning">
                    <p><strong>Based on:</strong> NAD+ at 15.2 nmol/ml (24% below lower limit), diagnosed niacin deficiency (Jan 2025), epigenetic age +3.5 years, extensive T-cell senescence (CD8+CD28- 58%).</p>
                  </div>
                </div>
                <span class="certainty-badge confirmed">CONFIRMED</span>
              </div>

              <p>NAD+ is critical for mitochondrial energy production and sirtuin activity (cellular longevity pathways). At 15.2 nmol/ml, the patient has impaired mitochondrial function, reduced sirtuin activity, and impaired DNA repair. The mechanistic connection: chronic infection/inflammation causes DNA damage, activating PARP enzymes that consume NAD+, which then impairs immune cell function, creating a vicious cycle.<sup><a href="#ref-7">[7]</a></sup></p>

              <table class="data-table">
                <thead>
                  <tr>
                    <th>Marker</th>
                    <th class="value-col">Value</th>
                    <th>Date</th>
                    <th class="ref-col">Reference</th>
                    <th class="status-cell">Status</th>
                  </tr>
                </thead>
                <tbody>
                  <tr class="row-critical">
                    <td>NAD+</td>
                    <td class="value-col">15.2 nmol/ml</td>
                    <td>Sept 2025</td>
                    <td class="ref-col">20-42</td>
                    <td class="status-cell"><span class="finding-tag tag-critical">Depleted</span></td>
                  </tr>
                  <tr class="row-warning">
                    <td>OMICm Age Difference</td>
                    <td class="value-col">+3.5 years</td>
                    <td>June 2025</td>
                    <td class="ref-col">0</td>
                    <td class="status-cell"><span class="finding-tag tag-warning">Accelerated</span></td>
                  </tr>
                  <tr class="row-ok">
                    <td>Dunedin PACE</td>
                    <td class="value-col">0.8</td>
                    <td>Sept 2025</td>
                    <td class="ref-col">&lt;1.0</td>
                    <td class="status-cell"><span class="finding-tag tag-moderate">Favorable</span></td>
                  </tr>
                  <tr class="row-critical">
                    <td>CD8+CD28- (senescent)</td>
                    <td class="value-col">58%</td>
                    <td>July 2025</td>
                    <td class="ref-col">&lt;30%</td>
                    <td class="status-cell"><span class="finding-tag tag-critical">Highly Elevated</span></td>
                  </tr>
                </tbody>
              </table>

              <div class="callout callout-green">
                <strong>Positive Finding</strong>
                <p>Dunedin PACE at 0.8 indicates the current pace of aging is favorable (<1.0 means aging slower than average). This suggests recent interventions may be working, but accumulated "biological debt" from chronic infection/stress remains visible in epigenetic markers. With appropriate intervention, the aging trajectory can be improved.</p>
              </div>

              <div class="callout callout-amber">
                <strong>Regulatory Note: NAD+ Precursor Supplements</strong>
                <p>NMN's status as a dietary supplement is under FDA review. Nicotinamide riboside (NR) products from established brands remain available and have demonstrated efficacy in clinical trials. A 2019 randomized controlled trial showed 300mg NR daily achieved a 51% increase in blood NAD+ levels after 2 weeks. For this reason, the therapeutic protocol recommends NR-based products.<sup><a href="#ref-7">[7]</a></sup></p>
              </div>
            </div>
          </div>

          <!-- Story 6: Cardiovascular -->
          <div class="finding priority-medium">
            <div class="finding-header collapsible" onclick="toggleSection(this)">
              <span class="finding-title">6. Cardiovascular Risk from Chronic Inflammation</span>
              <span class="finding-tag tag-warning">Confirmed - Atypical Profile</span>
            </div>
            <div class="finding-body collapsible-content">
              <p>This patient has an <strong>atypical cardiovascular risk profile</strong> - excellent lipid panel (LDL 1.2 mmol/L, HDL 1.35 mmol/L, ApoB 0.49 g/L) but inflammatory markers elevated. The D-dimer volatility (270-570 ng/mL) correlates with infection activity.<sup><a href="#ref-9">[9]</a></sup> Traditional lipid-focused strategies are insufficient - primary focus should be on treating infections and reducing inflammation.<sup><a href="#ref-29">[29]</a></sup></p>

              <table class="data-table">
                <thead>
                  <tr>
                    <th>Marker</th>
                    <th class="value-col">Value</th>
                    <th>Date</th>
                    <th class="ref-col">Reference</th>
                    <th class="status-cell">Status</th>
                  </tr>
                </thead>
                <tbody>
                  <tr class="row-warning">
                    <td>D-Dimer</td>
                    <td class="value-col">570 ng/mL</td>
                    <td>Oct 2025</td>
                    <td class="ref-col">&lt;500</td>
                    <td class="status-cell"><span class="finding-tag tag-warning">Elevated</span></td>
                  </tr>
                  <tr class="row-ok">
                    <td>Total Cholesterol</td>
                    <td class="value-col">3.0 mmol/L</td>
                    <td>Nov 2025</td>
                    <td class="ref-col">&lt;5.2</td>
                    <td class="status-cell"><span class="finding-tag tag-moderate">Optimal</span></td>
                  </tr>
                  <tr class="row-ok">
                    <td>LDL Cholesterol</td>
                    <td class="value-col">1.2 mmol/L</td>
                    <td>Nov 2025</td>
                    <td class="ref-col">&lt;2.6</td>
                    <td class="status-cell"><span class="finding-tag tag-moderate">Optimal</span></td>
                  </tr>
                  <tr class="row-ok">
                    <td>ApoB</td>
                    <td class="value-col">0.49 g/L</td>
                    <td>Nov 2025</td>
                    <td class="ref-col">0.63-1.33</td>
                    <td class="status-cell"><span class="finding-tag tag-moderate">Low (Favorable)</span></td>
                  </tr>
                  <tr class="row-ok">
                    <td>Homocysteine</td>
                    <td class="value-col">9.1 umol/L</td>
                    <td>Nov 2025</td>
                    <td class="ref-col">5-15</td>
                    <td class="status-cell"><span class="finding-tag tag-moderate">Normal</span></td>
                  </tr>
                </tbody>
              </table>
            </div>
          </div>

          <!-- Story 7: Gut Dysbiosis -->
          <div class="finding priority-medium">
            <div class="finding-header collapsible" onclick="toggleSection(this)">
              <span class="finding-title">7. Gut Dysbiosis and Digestive Dysfunction</span>
              <span class="finding-tag tag-warning">Probable</span>
            </div>
            <div class="finding-body collapsible-content">
              <p>The gut microbiome shows severe depletion of key beneficial species. Akkermansia muciniphila is <strong>undetectable</strong> - this keystone species maintains gut barrier integrity and is associated with metabolic health and insulin sensitivity.<sup><a href="#ref-26">[26]</a></sup> Bifidobacterium species are depleted, and elevated methane (16 ppm vs <10) indicates intestinal methanogen overgrowth (IMO). Low pancreatic elastase (85 vs >200) suggests exocrine pancreatic insufficiency.</p>

              <table class="data-table">
                <thead>
                  <tr>
                    <th>Marker</th>
                    <th class="value-col">Value</th>
                    <th>Date</th>
                    <th class="ref-col">Reference</th>
                    <th class="status-cell">Status</th>
                  </tr>
                </thead>
                <tbody>
                  <tr class="row-critical">
                    <td>Akkermansia muciniphila</td>
                    <td class="value-col">&lt;DL</td>
                    <td>Dec 2025</td>
                    <td class="ref-col">1.00-50.00</td>
                    <td class="status-cell"><span class="finding-tag tag-critical">Undetectable</span></td>
                  </tr>
                  <tr class="row-warning">
                    <td>Pancreatic Elastase</td>
                    <td class="value-col">85</td>
                    <td>2025</td>
                    <td class="ref-col">&gt;200</td>
                    <td class="status-cell"><span class="finding-tag tag-warning">Low</span></td>
                  </tr>
                  <tr class="row-warning">
                    <td>Methane</td>
                    <td class="value-col">16 ppm</td>
                    <td>2025</td>
                    <td class="ref-col">&lt;10</td>
                    <td class="status-cell"><span class="finding-tag tag-warning">Elevated</span></td>
                  </tr>
                </tbody>
              </table>
            </div>
          </div>

          <!-- Story 8: Heavy Metals -->
          <div class="finding priority-medium">
            <div class="finding-header collapsible" onclick="toggleSection(this)">
              <span class="finding-title">8. Heavy Metal Burden with Genetic Detox Vulnerability</span>
              <span class="finding-tag tag-warning">Probable</span>
            </div>
            <div class="finding-body collapsible-content">
              <p>The patient carries GPX1 rs1050450 AG genotype, conferring <strong>moderately reduced glutathione peroxidase activity</strong>. Combined with elevated cadmium (0.12 vs <0.065 ug/g hair) and borderline lead (0.75 vs <0.8 ug/g), this creates a "double-hit" of increased exposure with impaired detoxification capacity. Selenium supplementation may partially compensate for the GPX1 variant.</p>

              <table class="data-table">
                <thead>
                  <tr>
                    <th>Marker</th>
                    <th class="value-col">Value</th>
                    <th>Date</th>
                    <th class="ref-col">Reference</th>
                    <th class="status-cell">Status</th>
                  </tr>
                </thead>
                <tbody>
                  <tr class="row-critical">
                    <td>Cadmium (Hair)</td>
                    <td class="value-col">0.12 ug/g</td>
                    <td>June 2025</td>
                    <td class="ref-col">&lt;0.065</td>
                    <td class="status-cell"><span class="finding-tag tag-critical">Elevated</span></td>
                  </tr>
                  <tr class="row-warning">
                    <td>Lead (Hair)</td>
                    <td class="value-col">0.75 ug/g</td>
                    <td>June 2025</td>
                    <td class="ref-col">&lt;0.8</td>
                    <td class="status-cell"><span class="finding-tag tag-warning">Borderline</span></td>
                  </tr>
                  <tr class="row-warning">
                    <td>GPX1 Genotype</td>
                    <td class="value-col">AG</td>
                    <td>Genetic</td>
                    <td class="ref-col">GG (wild)</td>
                    <td class="status-cell"><span class="finding-tag tag-warning">Risk Variant</span></td>
                  </tr>
                </tbody>
              </table>
            </div>
          </div>
        </div>
      </section>

      <!-- Root Cause Analysis -->
      <section class="section">
        <h2 class="section-title"><span class="icon">&#128269;</span> Root Cause Analysis</h2>

        <div class="root-cause-visual">
          <div class="root-cause-hub">
            ROOT CAUSE: Chronic Intracellular Infections<br>
            <small>(Mycoplasma, Schistosoma)</small>
          </div>
          <div class="root-cause-spokes">
            <div class="spoke">
              <div class="spoke-title">HPA Axis Exhaustion</div>
              <div class="spoke-body">Chronic infection creates sustained immune activation requiring cortisol modulation. Over time, this depletes DHEA and catecholamine reserves (Severity 8/10).</div>
            </div>
            <div class="spoke">
              <div class="spoke-title">Immune Exhaustion</div>
              <div class="spoke-body">Elevated cortisol:DHEA ratio (7.2) suppresses NK cell function and cytotoxic T-cell activity, allowing infection persistence. CD57 depleted to 70/uL.</div>
            </div>
            <div class="spoke">
              <div class="spoke-title">Metabolic Dysfunction</div>
              <div class="spoke-body">Chronic cortisol elevation promotes insulin resistance. Inflammatory cytokines impair insulin signaling. Result: 5x elevated fasting insulin.</div>
            </div>
            <div class="spoke">
              <div class="spoke-title">NAD+ Depletion</div>
              <div class="spoke-body">DNA damage from chronic inflammation activates PARP enzymes that consume NAD+. Result: 15.2 nmol/ml (24% below lower limit).</div>
            </div>
            <div class="spoke">
              <div class="spoke-title">Cardiovascular Risk</div>
              <div class="spoke-body">Chronic inflammation activates coagulation cascade. D-dimer volatile (270-570 ng/mL). Atherosclerotic coronary disease documented.</div>
            </div>
            <div class="spoke">
              <div class="spoke-title">Accelerated Aging</div>
              <div class="spoke-body">All pathways converge: mitochondrial dysfunction, T-cell senescence (58%), NAD+ depletion. Result: +3.5 years epigenetic age.</div>
            </div>
          </div>
        </div>

        <div class="callout">
          <strong>The Vicious Cycle</strong>
          <p>Chronic intracellular infections drive HPA activation, which impairs immune clearance, which allows infection persistence, which drives further HPA activation. Breaking this cycle requires addressing the infections as the primary target while supporting all affected systems concurrently.</p>
        </div>
      </section>

      <!-- Biomarker Trends -->
      <section class="section">
        <h2 class="section-title"><span class="icon">&#128202;</span> Biomarker Trend Analysis</h2>

        <div class="chart-row">
          <div class="chart-container">
            <h3>Ferritin Trend (Critical Decline)</h3>
            <div class="trend-chart">
              <canvas id="ferritinTrend"></canvas>
            </div>
            <div class="trend-insight declining">
              <strong>Trend Analysis:</strong> Rapid 81% decline from 101 to 19 ug/L over 12 months. Now below reference range. Urgent GI evaluation required.
            </div>
          </div>
          <div class="chart-container">
            <h3>D-Dimer Volatility</h3>
            <div class="trend-chart">
              <canvas id="ddimerTrend"></canvas>
            </div>
            <div class="trend-insight declining">
              <strong>Trend Analysis:</strong> Volatile pattern (270-570 ng/mL) correlating with infection activity. Recent spike suggests active inflammatory process.
            </div>
          </div>
        </div>

        <div class="chart-row">
          <div class="chart-container">
            <h3>Homocysteine Improvement</h3>
            <div class="trend-chart">
              <canvas id="homocysteineTrend"></canvas>
            </div>
            <div class="trend-insight improving">
              <strong>Trend Analysis:</strong> Improved from 19.8 to 9.1 umol/L. B vitamin optimization showing results. Target &lt;7 umol/L for optimal longevity.
            </div>
          </div>
          <div class="chart-container">
            <h3>Insulin (Serum) - Hidden Resistance</h3>
            <div class="trend-chart">
              <canvas id="insulinTrend"></canvas>
            </div>
            <div class="trend-insight declining">
              <strong>Trend Analysis:</strong> Values ranging 11-30 uIU/mL with most recent at 28 uIU/mL. GLP-1 agonist intervention recommended.
            </div>
          </div>
        </div>

        <div class="chart-container">
          <h3>System Health Overview</h3>
          <div class="trend-chart">
            <canvas id="systemsRadar"></canvas>
          </div>
        </div>
      </section>

      <!-- Data Gaps Section -->
      <section class="section">
        <div class="data-gaps">
          <h3>Data Gaps & Limitations</h3>
          <p>The following data gaps affect analysis confidence and should be addressed:</p>

          <div class="data-gaps-grid">
            <div class="gap-card">
              <h4>hs-CRP Missing</h4>
              <p><strong>Impact:</strong> Cannot fully assess systemic inflammation level for cardiovascular risk stratification.</p>
              <p><strong>Recommendation:</strong> Order hs-CRP with next blood work.</p>
            </div>
            <div class="gap-card">
              <h4>Medication History Empty</h4>
              <p><strong>Impact:</strong> Cannot assess drug-biomarker interactions or supplement interactions.</p>
              <p><strong>Recommendation:</strong> Obtain complete medication/supplement list from patient.</p>
            </div>
            <div class="gap-card">
              <h4>Patient Demographics Unknown</h4>
              <p><strong>Impact:</strong> Cannot apply age/gender-specific reference ranges.</p>
              <p><strong>Recommendation:</strong> Verify DOB and gender for refined interpretation.</p>
            </div>
            <div class="gap-card">
              <h4>DHEA-S Not Measured</h4>
              <p><strong>Impact:</strong> Cannot quantify DHEA deficiency severity precisely.</p>
              <p><strong>Recommendation:</strong> Order DHEA-S to guide supplementation dosing.</p>
            </div>
          </div>
        </div>
      </section>

      <!-- Therapeutic Protocol -->
      <section class="section">
        <h2 class="section-title"><span class="icon">&#128138;</span> Therapeutic Protocol</h2>

        <div class="actions-grid">
          <div class="action-card">
            <div class="action-card-header">
              <span class="dot red"></span>
              Phase 1: Immediate (0-3 Months)
            </div>
            <div class="action-card-body">
              <ul>
                <li><strong>GI Evaluation (URGENT):</strong> Colonoscopy/endoscopy to identify blood loss source</li>
                <li><strong>Infectious Disease Consultation:</strong> Targeted antimicrobial therapy for Mycoplasma/Schistosoma</li>
                <li><strong>Iron Supplementation:</strong> Ferrous bisglycinate 25-50mg daily with vitamin C <a href="https://www.thorne.com/products/dp/iron-bisglycinate" target="_blank" rel="noopener noreferrer">[Thorne]</a><sup><a href="#ref-11">[11]</a></sup></li>
                <li><strong>GLP-1 Agonist:</strong> Semaglutide 0.25mg weekly, titrate to 1.0mg<sup><a href="#ref-5">[5]</a></sup><sup><a href="#ref-30">[30]</a></sup></li>
              </ul>
            </div>
          </div>
          <div class="action-card">
            <div class="action-card-header">
              <span class="dot amber"></span>
              Phase 1: High Priority Supplements
            </div>
            <div class="action-card-body">
              <ul>
                <li><strong>DHEA:</strong> 25-50mg morning <a href="https://pureencapsulations.com/dhea-25-mg-2282.html" target="_blank" rel="noopener noreferrer">[Pure Encapsulations]</a><sup><a href="#ref-1">[1]</a></sup></li>
                <li><strong>NAD+ Precursor (NR):</strong> 300mg daily <a href="https://www.lifeextension.com/vitamins-supplements/item02344/nad-cell-regenerator" target="_blank" rel="noopener noreferrer">[Life Extension NAD+ Cell Regenerator]</a><sup><a href="#ref-7">[7]</a></sup> <span style="font-size:0.85em;color:#666;">(Note: NR preferred; NMN regulatory status uncertain)</span></li>
                <li><strong>Methylated B Complex:</strong> Methylfolate 1mg + Methylcobalamin 1000mcg + P5P 50mg <a href="https://www.thorne.com/products/dp/methyl-guard-plus-reg" target="_blank" rel="noopener noreferrer">[Thorne Methyl-Guard Plus]</a><sup><a href="#ref-10">[10]</a></sup></li>
                <li><strong>Zinc:</strong> 30mg daily for immune support <a href="https://www.thorne.com/products/dp/zinc-picolinate-30-mg" target="_blank" rel="noopener noreferrer">[Thorne]</a></li>
              </ul>
            </div>
          </div>
          <div class="action-card">
            <div class="action-card-header">
              <span class="dot green"></span>
              Phase 2: Stabilization (3-6 Months)
            </div>
            <div class="action-card-body">
              <ul>
                <li><strong>Adaptogens:</strong> Ashwagandha 300-600mg, Rhodiola 200-400mg <a href="https://www.jarrow.com/product/388/Ashwagandha" target="_blank" rel="noopener noreferrer">[Jarrow]</a></li>
                <li><strong>Selenium:</strong> 200mcg daily (GPX1 support) <a href="https://www.lifeextension.com/vitamins-supplements/item01778/se-methyl-l-selenocysteine" target="_blank" rel="noopener noreferrer">[Life Extension]</a></li>
                <li><strong>NAC:</strong> 1200mg daily for detoxification <a href="https://www.pureencapsulationspro.com/nac-n-acetyl-l-cysteine-600-mg.html" target="_blank" rel="noopener noreferrer">[Pure Encapsulations]</a></li>
                <li><strong>Liposomal Glutathione:</strong> 500mg daily <a href="https://www.quicksilverscientific.com/products/glutathione-complex" target="_blank" rel="noopener noreferrer">[Quicksilver Scientific]</a></li>
              </ul>
            </div>
          </div>
          <div class="action-card">
            <div class="action-card-header">
              <span class="dot brand"></span>
              Phase 3: Optimization (6-12 Months)
            </div>
            <div class="action-card-body">
              <ul>
                <li><strong>Reassess all biomarkers:</strong> Expect CD57 increase, insulin decrease, ferritin normalization</li>
                <li><strong>IV NAD+ therapy:</strong> Consider if oral repletion insufficient</li>
                <li><strong>Chelation evaluation:</strong> If heavy metals remain elevated after support</li>
                <li><strong>Longevity optimization:</strong> Target OMICm Age normalization</li>
              </ul>
            </div>
          </div>
        </div>

        <h3 style="margin: 24px 0 16px;">Daily Supplement Schedule</h3>
        <table class="schedule-table">
          <thead>
            <tr>
              <th class="time-col">Time</th>
              <th>Supplements</th>
              <th class="notes-col">Notes</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td class="time-col">Morning (empty stomach)</td>
              <td>DHEA 25-50mg</td>
              <td class="notes-col">Take 30 min before breakfast; mirrors natural cortisol rhythm</td>
            </tr>
            <tr>
              <td class="time-col">With Breakfast</td>
              <td>Methylated B Complex, Zinc 30mg, NAD+ Precursor (NR) 300mg</td>
              <td class="notes-col">B vitamins best absorbed with food; zinc with food reduces nausea</td>
            </tr>
            <tr>
              <td class="time-col">With Lunch</td>
              <td>Iron bisglycinate 25mg + Vitamin C</td>
              <td class="notes-col">Separate from calcium by 2+ hours; vitamin C enhances absorption</td>
            </tr>
            <tr>
              <td class="time-col">Afternoon (3-4pm)</td>
              <td>Ashwagandha 300mg, Rhodiola 200mg (if using)</td>
              <td class="notes-col">Adaptogens can be mildly stimulating; avoid evening</td>
            </tr>
            <tr>
              <td class="time-col">With Dinner</td>
              <td>Selenium 200mcg, NAC 600mg, Liposomal Glutathione 250mg</td>
              <td class="notes-col">Detox support with evening meal</td>
            </tr>
            <tr>
              <td class="time-col">Before Bed</td>
              <td>NAC 600mg (2nd dose), Liposomal Glutathione 250mg (2nd dose)</td>
              <td class="notes-col">Split dosing maintains levels; supports overnight detoxification</td>
            </tr>
          </tbody>
        </table>
      </section>

      <!-- Testing Recommendations -->
      <section class="section">
        <h2 class="section-title"><span class="icon">&#128300;</span> Testing Recommendations</h2>

        <div class="followup-grid">
          <div class="followup-item">
            <h4>Ferritin + CBC</h4>
            <div class="followup-when">Monthly x 3 months</div>
            <p>Monitor iron repletion and RBC recovery. Target ferritin >50 ug/L.</p>
          </div>
          <div class="followup-item">
            <h4>Fasting Insulin</h4>
            <div class="followup-when">Monthly x 3 months</div>
            <p>Track metabolic response to GLP-1 agonist. Target <15 uIU/mL.</p>
          </div>
          <div class="followup-item">
            <h4>CD57 NK Cells</h4>
            <div class="followup-when">Quarterly</div>
            <p>Infection treatment response marker. Expect increase with successful clearance.</p>
          </div>
          <div class="followup-item">
            <h4>Cortisol:DHEA Ratio</h4>
            <div class="followup-when">Quarterly</div>
            <p>HPA axis recovery marker. Target ratio <5.0.</p>
          </div>
          <div class="followup-item">
            <h4>NAD+ Levels</h4>
            <div class="followup-when">Quarterly</div>
            <p>Confirm repletion from NAD+ precursor (NR) supplementation. Target >25 nmol/ml.</p>
          </div>
          <div class="followup-item">
            <h4>D-Dimer</h4>
            <div class="followup-when">Quarterly</div>
            <p>Inflammation/treatment response marker. Target <500 ng/mL consistently.</p>
          </div>
          <div class="followup-item">
            <h4>Comprehensive Immune Panel</h4>
            <div class="followup-when">Semi-Annual</div>
            <p>CD4/CD8, T-cell subsets, NK cell function. Assess immune recovery.</p>
          </div>
          <div class="followup-item">
            <h4>Epigenetic Age</h4>
            <div class="followup-when">Semi-Annual</div>
            <p>Dunedin PACE, OMICm Age. Target reduction of +3.5 year gap.</p>
          </div>
        </div>
      </section>

      <!-- Longevity Assessment -->
      <section class="section">
        <h2 class="section-title"><span class="icon">&#9201;</span> Longevity Assessment</h2>

        <p>This patient has epigenetic clock data available, providing Tier 1-level assessment capability.</p>

        <div class="prognosis-bar-container">
          <p><strong>Biological Age Status:</strong></p>
          <div class="prognosis-bar">
            <div class="prognosis-marker" style="left: 62%;"></div>
          </div>
          <div class="prognosis-labels">
            <span>Younger than chronological age</span>
            <span>Same as chronological</span>
            <span>Older than chronological age</span>
          </div>
        </div>

        <div class="longevity-disclaimer">
          <h4>Biological Age Assessment (Tier 1 - Epigenetic Data Available)</h4>
          <table class="disclaimer-details">
            <tr><td><strong>OMICm Age Difference:</strong></td><td>+3.5 years (accelerated aging)</td></tr>
            <tr><td><strong>Dunedin PACE:</strong></td><td>0.8 (favorable - currently aging slower)</td></tr>
            <tr><td><strong>Interpretation:</strong></td><td>Past damage accumulated, but current pace favorable</td></tr>
          </table>
          <p class="improvement-path"><strong>Paradoxical Pattern:</strong> Epigenetic age is older (+3.5 years of accumulated "biological debt"), but current pace of aging (0.8) is favorable.<sup><a href="#ref-27">[27]</a></sup> This suggests recent interventions may be slowing aging, but historical damage from chronic infection/stress remains visible. With appropriate treatment of root causes, epigenetic age gap can be reduced.</p>
        </div>

        <h3 style="margin: 24px 0 16px;">Key Longevity Biomarkers</h3>
        <table class="data-table">
          <thead>
            <tr>
              <th>Marker</th>
              <th class="value-col">Patient Value</th>
              <th>Longevity Target</th>
              <th class="status-cell">Status</th>
            </tr>
          </thead>
          <tbody>
            <tr class="row-critical">
              <td>Fasting Insulin</td>
              <td class="value-col">28.3 uIU/mL</td>
              <td>&lt;5 uIU/mL</td>
              <td class="status-cell"><span class="finding-tag tag-critical">Poor</span></td>
            </tr>
            <tr class="row-critical">
              <td>NAD+</td>
              <td class="value-col">15.2 nmol/ml</td>
              <td>&gt;30 nmol/ml</td>
              <td class="status-cell"><span class="finding-tag tag-critical">Depleted</span></td>
            </tr>
            <tr class="row-warning">
              <td>Homocysteine</td>
              <td class="value-col">9.1 umol/L</td>
              <td>&lt;7 umol/L</td>
              <td class="status-cell"><span class="finding-tag tag-warning">Suboptimal</span></td>
            </tr>
            <tr class="row-warning">
              <td>HbA1c</td>
              <td class="value-col">5.6%</td>
              <td>&lt;5.4%</td>
              <td class="status-cell"><span class="finding-tag tag-warning">Borderline</span></td>
            </tr>
            <tr class="row-ok">
              <td>Triglyceride/HDL Ratio</td>
              <td class="value-col">0.81</td>
              <td>&lt;1.5</td>
              <td class="status-cell"><span class="finding-tag tag-moderate">Excellent</span></td>
            </tr>
            <tr class="row-ok">
              <td>ApoB</td>
              <td class="value-col">0.49 g/L</td>
              <td>&lt;0.7 g/L</td>
              <td class="status-cell"><span class="finding-tag tag-moderate">Excellent</span></td>
            </tr>
          </tbody>
        </table>
      </section>

      <!-- Health Journey Timeline -->
      <section class="section">
        <h2 class="section-title collapsible" onclick="toggleSection(this)"><span class="icon">&#128197;</span> Health Journey Timeline</h2>
        <div class="collapsible-content">
          <div class="timeline">
            <div class="tl-item">
              <span class="tl-dot tl-amber"></span>
              <div class="tl-date">September 2015</div>
              <div class="tl-content">
                <div class="tl-name">First Documented Diagnosis</div>
                <div class="tl-change">Plantar fibroma identified - early sign of connective tissue susceptibility</div>
              </div>
            </div>
            <div class="tl-item">
              <span class="tl-dot tl-amber"></span>
              <div class="tl-date">July 2022</div>
              <div class="tl-content">
                <div class="tl-name">Chronic Conditions Emerge</div>
                <div class="tl-change">Hypertension and Diabetes documented</div>
              </div>
            </div>
            <div class="tl-item">
              <span class="tl-dot tl-amber"></span>
              <div class="tl-date">April 2024</div>
              <div class="tl-content">
                <div class="tl-name">Cardiac Finding</div>
                <div class="tl-change">Excessive Overload of Left Atrium identified - cardiovascular strain</div>
              </div>
            </div>
            <div class="tl-item">
              <span class="tl-dot tl-red"></span>
              <div class="tl-date">July 2024</div>
              <div class="tl-content">
                <div class="tl-name">GI Crisis</div>
                <div class="tl-change">Acute gastritis and colitis diagnosed; Hemorrhoidectomy performed (July 15)</div>
              </div>
            </div>
            <div class="tl-item">
              <span class="tl-dot tl-red"></span>
              <div class="tl-date">October-November 2024</div>
              <div class="tl-content">
                <div class="tl-name">Endocrine Dysfunction Documented</div>
                <div class="tl-change">DHEA deficiency and adrenal insufficiency formally diagnosed; Cortisol:DHEA ratio 7.2</div>
              </div>
            </div>
            <div class="tl-item">
              <span class="tl-dot tl-amber"></span>
              <div class="tl-date">December 2024</div>
              <div class="tl-content">
                <div class="tl-name">Ferritin Baseline</div>
                <div class="tl-change">Ferritin at 101 ug/L - adequate stores before decline begins</div>
              </div>
            </div>
            <div class="tl-item">
              <span class="tl-dot tl-amber"></span>
              <div class="tl-date">January 2025</div>
              <div class="tl-content">
                <div class="tl-name">Niacin Deficiency</div>
                <div class="tl-change">NAD+ depletion pathway identified; Niacin deficiency diagnosed</div>
              </div>
            </div>
            <div class="tl-item">
              <span class="tl-dot tl-amber"></span>
              <div class="tl-date">April 2025</div>
              <div class="tl-content">
                <div class="tl-name">Musculoskeletal Issues</div>
                <div class="tl-change">Bilateral shoulder pathology emerges (bursitis, partial tears); Cervical disc bulges</div>
              </div>
            </div>
            <div class="tl-item">
              <span class="tl-dot tl-red"></span>
              <div class="tl-date">July 2025</div>
              <div class="tl-content">
                <div class="tl-name">Peak Severity</div>
                <div class="tl-change">Severe adrenal medulla exhaustion (Severity 8); Active Mycoplasma and Schistosoma documented</div>
              </div>
            </div>
            <div class="tl-item">
              <span class="tl-dot tl-red"></span>
              <div class="tl-date">September 2025</div>
              <div class="tl-content">
                <div class="tl-name">NAD+ Crisis</div>
                <div class="tl-change">NAD+ measured at 15.2 nmol/ml - 24% below lower limit</div>
              </div>
            </div>
            <div class="tl-item">
              <span class="tl-dot tl-red"></span>
              <div class="tl-date">October-November 2025</div>
              <div class="tl-content">
                <div class="tl-name">Current Crossroads</div>
                <div class="tl-change">D-dimer 570 ng/mL; Insulin 28 uIU/mL; Ferritin 19 ug/L (below range)</div>
              </div>
            </div>
            <div class="tl-item">
              <span class="tl-dot tl-amber"></span>
              <div class="tl-date">December 2025</div>
              <div class="tl-content">
                <div class="tl-name">Gut Microbiome Analysis</div>
                <div class="tl-change">Akkermansia undetectable; Severe dysbiosis documented</div>
              </div>
            </div>
          </div>
        </div>
      </section>

      <!-- References -->
      <section class="section">
        <h2 class="section-title"><span class="icon">&#128214;</span> References</h2>
        <ol class="reference-list">
          <li id="ref-1">NCBI Bookshelf (2024). "Adrenal Insufficiency - StatPearls." StatPearls. PMID: NBK441832. <a href="https://www.ncbi.nlm.nih.gov/books/NBK441832/" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/books/NBK441832/</a></li>
          <li id="ref-2">PMC (2024). "Adrenal and Metabolic Hormonal Axes Shape Anti-Tuberculosis Immune Responses in HIV-TB Coinfection." PMC: PMC12880830. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12880830/" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12880830/</a></li>
          <li id="ref-3">Stricker RB, Winger EE (2001). "Decreased CD57 lymphocyte subset in patients with chronic Lyme disease." Immunol Lett. DOI: 10.1016/S0165-2478(00)00316-3. PMID: 11222912. <a href="https://pubmed.ncbi.nlm.nih.gov/11222912/" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/11222912/</a></li>
          <li id="ref-4">Marques A et al. (2009). "Natural Killer Cell Counts Are Not Different between Patients with Post-Lyme Disease Syndrome and Controls." Clin Vaccine Immunol. PMC: PMC2725528. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725528/" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725528/</a></li>
          <li id="ref-5">Multiple Authors (2021). "A meta-analysis of the effects of GLP1-RA in NAFLD with T2D." Scientific Reports. DOI: 10.1038/s41598-021-01663-y. <a href="https://doi.org/10.1038/s41598-021-01663-y" target="_blank" rel="noopener noreferrer">https://doi.org/10.1038/s41598-021-01663-y</a></li>
          <li id="ref-6">Multiple Authors (2024). "Effects of GLP-1 RA on resolution of steatohepatitis in NAFLD." J Canadian Assoc Gastroenterol.</li>
          <li id="ref-7">Multiple Authors (2025). "The role of NAD+ metabolism and its modulation of mitochondria in aging and disease." npj Metabolic Health Disease. PMID: 40604314. <a href="https://pubmed.ncbi.nlm.nih.gov/40604314/" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/40604314/</a></li>
          <li id="ref-8">Zhang H et al. (2016). "NAD+ repletion improves mitochondrial and stem cell function and enhances life span in mice." Science. DOI: 10.1126/science.aaf2693. <a href="https://doi.org/10.1126/science.aaf2693" target="_blank" rel="noopener noreferrer">https://doi.org/10.1126/science.aaf2693</a></li>
          <li id="ref-9">Moss AJ et al. (2018). "D-Dimer for Long-Term Risk Prediction in Patients After Acute Coronary Syndrome." Circulation. DOI: 10.1161/CIRCULATIONAHA.118.033670. <a href="https://doi.org/10.1161/CIRCULATIONAHA.118.033670" target="_blank" rel="noopener noreferrer">https://doi.org/10.1161/CIRCULATIONAHA.118.033670</a></li>
          <li id="ref-10">Rui-Jing et al. (2025). "Homocysteine in the Cardiovascular Setting." J Cardiovasc Dev Dis. PMC: PMC12564181. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12564181/" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12564181/</a></li>
          <li id="ref-11">Tolkien Z et al. (2015). "Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis." PLoS One. DOI: 10.1371/journal.pone.0117383. <a href="https://doi.org/10.1371/journal.pone.0117383" target="_blank" rel="noopener noreferrer">https://doi.org/10.1371/journal.pone.0117383</a></li>
          <li id="ref-12">Loprinzi CL et al. (2010). "Phase III controlled evaluation of DHEA for improving quality of life in cancer survivors." JAMA. DOI: 10.1001/jama.2010.1243.</li>
          <li id="ref-13">Yen SS et al. (1995). "Replacement of DHEA in aging men and women." Ann N Y Acad Sci. PMID: 8526330.</li>
          <li id="ref-14">Couzin-Frankel J (2013). "Aging genes: the sirtuin story unravels." Science. DOI: 10.1126/science.334.6060.1194.</li>
          <li id="ref-15">Verdin E (2015). "NAD+ in aging, metabolism, and neurodegeneration." Science. DOI: 10.1126/science.aac4854.</li>
          <li id="ref-16">Covarrubias AJ et al. (2021). "NAD+ metabolism and its roles in cellular processes during ageing." Nat Rev Mol Cell Biol. DOI: 10.1038/s41580-020-00313-x.</li>
          <li id="ref-17">Belsky DW et al. (2022). "Quantification of the pace of biological aging in humans through a blood test, the DunedinPoAm DNA methylation algorithm." eLife. DOI: 10.7554/eLife.73420.</li>
          <li id="ref-18">Lopez-Otin C et al. (2023). "Hallmarks of aging: An expanding universe." Cell. DOI: 10.1016/j.cell.2022.11.001.</li>
          <li id="ref-19">Rayman MP (2012). "Selenium and human health." Lancet. DOI: 10.1016/S0140-6736(11)61452-9.</li>
          <li id="ref-20">Loscalzo J (2014). "Oxidative stress in atherosclerosis." Arterioscler Thromb Vasc Biol. DOI: 10.1161/ATVBAHA.114.303038.</li>
          <li id="ref-21">Derosa G et al. (2016). "Effects of berberine on lipid profile in subjects with low cardiovascular risk." Expert Opin Biol Ther. PMID: 26950537.</li>
          <li id="ref-22">Plovier H et al. (2017). "A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice." Nat Med. DOI: 10.1038/nm.4236.</li>
          <li id="ref-23">Chandrasekaran A et al. (2019). "Role of Akkermansia muciniphila in metabolic disease." Gut Microbes. DOI: 10.1080/19490976.2019.1640587.</li>
          <li id="ref-24">Chen Y et al. (2023). "Hyperinsulinemia: an early biomarker of metabolic dysfunction." Front Clin Diabetes Healthc. PMC: PMC10186728. <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10186728/" target="_blank" rel="noopener noreferrer">https://pmc.ncbi.nlm.nih.gov/articles/PMC10186728/</a></li>
          <li id="ref-25">American Gastroenterological Association (2024). "AGA Clinical Practice Update on Management of Iron Deficiency Anemia: Expert Review." Clin Gastroenterol Hepatol. <a href="https://www.cghjournal.org/article/S1542-3565(24)00410-5/fulltext" target="_blank" rel="noopener noreferrer">https://www.cghjournal.org/article/S1542-3565(24)00410-5/fulltext</a></li>
          <li id="ref-26">Zeng J et al. (2025). "Role of Akkermansia muciniphila in insulin resistance." J Gastroenterol Hepatol. PMID: 39396929. <a href="https://pubmed.ncbi.nlm.nih.gov/39396929/" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/39396929/</a></li>
          <li id="ref-27">Belsky DW et al. (2022). "DunedinPACE, a DNA methylation biomarker of the pace of aging." eLife. DOI: 10.7554/eLife.73420. PMC: PMC8853656. <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8853656/" target="_blank" rel="noopener noreferrer">https://pmc.ncbi.nlm.nih.gov/articles/PMC8853656/</a></li>
          <li id="ref-28">Kim JH et al. (2023). "Relationship between Serum Cortisol, DHEAS Levels, and Natural Killer Cell Activity." PMC: PMC10299486. <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10299486/" target="_blank" rel="noopener noreferrer">https://pmc.ncbi.nlm.nih.gov/articles/PMC10299486/</a></li>
          <li id="ref-29">American College of Cardiology (2025). "Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement." JACC. <a href="https://www.jacc.org/doi/10.1016/j.jacc.2025.08.047" target="_blank" rel="noopener noreferrer">https://www.jacc.org/doi/10.1016/j.jacc.2025.08.047</a></li>
          <li id="ref-30">Zhang Z et al. (2025). "Efficacy of GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists in managing MAFLD." BMC Gastroenterol. <a href="https://link.springer.com/article/10.1186/s12876-025-04358-0" target="_blank" rel="noopener noreferrer">https://link.springer.com/article/10.1186/s12876-025-04358-0</a></li>
        </ol>
      </section>

      <!-- Disclaimer -->
      <div class="report-disclaimer">
        <h3>Medical Disclaimer</h3>
        <p>This report is generated for informational purposes only and does not constitute medical advice, diagnosis, or treatment. The analysis is based on available data and should be interpreted by qualified healthcare professionals in the context of the patient's complete medical history, physical examination, and clinical judgment.</p>
        <p>All therapeutic recommendations should be discussed with and approved by the patient's treating physician before implementation. Supplement recommendations are based on available evidence but individual responses may vary. Some recommendations may require prescription medications that must be obtained through licensed healthcare providers.</p>
        <p>The biomarker interpretations and clinical correlations presented here are based on current medical literature and guidelines, but medical knowledge evolves continuously. Reference ranges and clinical significance may vary between laboratories and patient populations.</p>
        <p><strong>Emergency Warning:</strong> If you are experiencing a medical emergency, please call emergency services immediately. Do not delay care based on this report.</p>
      </div>
    </div>

    <!-- Footer -->
    <footer class="report-footer">
      <p>Generated by <a href="https://n1.care" target="_blank" rel="noopener noreferrer">n1.care</a> Comprehensive Health Analysis Platform</p>
      <p>Report Date: February 15, 2026 | Analysis Version 2.0</p>
    </footer>
  </div>

  <script>
    // Collapsible sections
    function toggleSection(header) {
      header.classList.toggle('active');
      const content = header.nextElementSibling;
      if (content && content.classList.contains('collapsible-content')) {
        content.classList.toggle('show');
      }
    }

    // Initialize all sections as collapsed except the first one in each finding
    document.addEventListener('DOMContentLoaded', function() {
      // Charts
      initializeCharts();
    });

    function initializeCharts() {
      // Ferritin Trend
      new Chart(document.getElementById('ferritinTrend'), {
        type: 'line',
        data: {
          labels: ['Oct 2024', 'Nov 2024', 'Dec 2024', 'Mar 2025', 'Oct 2025', 'Nov 2025'],
          datasets: [{
            label: 'Ferritin (ug/L)',
            data: [88, 92.5, 101, 36, 17.7, 19],
            borderColor: '#DC2626',
            backgroundColor: 'rgba(220, 38, 38, 0.1)',
            tension: 0.3,
            fill: true,
            pointRadius: 6,
            pointBackgroundColor: '#DC2626',
            pointBorderColor: '#fff',
            pointBorderWidth: 2
          }]
        },
        options: {
          responsive: true,
          maintainAspectRatio: false,
          plugins: {
            annotation: {
              annotations: {
                normalRange: {
                  type: 'box',
                  yMin: 22,
                  yMax: 150,
                  backgroundColor: 'rgba(34, 197, 94, 0.1)',
                  borderColor: 'rgba(34, 197, 94, 0.3)',
                  borderWidth: 1
                },
                lowerLimit: {
                  type: 'line',
                  yMin: 22,
                  yMax: 22,
                  borderColor: '#EA580C',
                  borderWidth: 2,
                  borderDash: [5, 5],
                  label: {
                    display: true,
                    content: 'Lower Limit (22)',
                    position: 'start'
                  }
                }
              }
            }
          },
          scales: {
            y: {
              beginAtZero: false,
              min: 0,
              max: 120,
              title: {
                display: true,
                text: 'Ferritin (ug/L)'
              }
            }
          }
        }
      });

      // D-Dimer Trend
      new Chart(document.getElementById('ddimerTrend'), {
        type: 'line',
        data: {
          labels: ['Oct 2024', 'Oct 2024', 'Mar 2025', 'May 2025', 'Oct 2025'],
          datasets: [{
            label: 'D-Dimer (ng/mL)',
            data: [560, 629, 320, 270, 570],
            borderColor: '#D97706',
            backgroundColor: 'rgba(217, 119, 6, 0.1)',
            tension: 0.3,
            fill: true,
            pointRadius: 6,
            pointBackgroundColor: '#D97706',
            pointBorderColor: '#fff',
            pointBorderWidth: 2
          }]
        },
        options: {
          responsive: true,
          maintainAspectRatio: false,
          plugins: {
            annotation: {
              annotations: {
                threshold: {
                  type: 'line',
                  yMin: 500,
                  yMax: 500,
                  borderColor: '#DC2626',
                  borderWidth: 2,
                  borderDash: [5, 5],
                  label: {
                    display: true,
                    content: 'Upper Limit (500)',
                    position: 'end'
                  }
                }
              }
            }
          },
          scales: {
            y: {
              beginAtZero: false,
              min: 200,
              max: 700,
              title: {
                display: true,
                text: 'D-Dimer (ng/mL)'
              }
            }
          }
        }
      });

      // Homocysteine Trend
      new Chart(document.getElementById('homocysteineTrend'), {
        type: 'line',
        data: {
          labels: ['Mar 2025', 'Mar 2025', 'May 2025', 'Jun 2025', 'Jul 2025', 'Sep 2025', 'Oct 2025', 'Nov 2025'],
          datasets: [{
            label: 'Homocysteine (umol/L)',
            data: [15.93, 10.9, 19.34, 19.8, 15.32, 19.31, 16.32, 9.1],
            borderColor: '#16A34A',
            backgroundColor: 'rgba(22, 163, 74, 0.1)',
            tension: 0.3,
            fill: true,
            pointRadius: 6,
            pointBackgroundColor: '#16A34A',
            pointBorderColor: '#fff',
            pointBorderWidth: 2
          }]
        },
        options: {
          responsive: true,
          maintainAspectRatio: false,
          plugins: {
            annotation: {
              annotations: {
                target: {
                  type: 'line',
                  yMin: 7,
                  yMax: 7,
                  borderColor: '#16A34A',
                  borderWidth: 2,
                  borderDash: [5, 5],
                  label: {
                    display: true,
                    content: 'Longevity Target (<7)',
                    position: 'start'
                  }
                },
                upper: {
                  type: 'line',
                  yMin: 15,
                  yMax: 15,
                  borderColor: '#DC2626',
                  borderWidth: 2,
                  borderDash: [5, 5],
                  label: {
                    display: true,
                    content: 'Upper Limit (15)',
                    position: 'end'
                  }
                }
              }
            }
          },
          scales: {
            y: {
              beginAtZero: false,
              min: 5,
              max: 25,
              title: {
                display: true,
                text: 'Homocysteine (umol/L)'
              }
            }
          }
        }
      });

      // Insulin Trend
      new Chart(document.getElementById('insulinTrend'), {
        type: 'line',
        data: {
          labels: ['May 2025', 'Jun 2025', 'Jul 2025', 'Sep 2025', 'Oct 2025'],
          datasets: [{
            label: 'Insulin (uIU/mL)',
            data: [17.6, 28, 11.4, 30.2, 28.3],
            borderColor: '#DC2626',
            backgroundColor: 'rgba(220, 38, 38, 0.1)',
            tension: 0.3,
            fill: true,
            pointRadius: 6,
            pointBackgroundColor: '#DC2626',
            pointBorderColor: '#fff',
            pointBorderWidth: 2
          }]
        },
        options: {
          responsive: true,
          maintainAspectRatio: false,
          plugins: {
            annotation: {
              annotations: {
                normalRange: {
                  type: 'box',
                  yMin: 3,
                  yMax: 25,
                  backgroundColor: 'rgba(34, 197, 94, 0.1)',
                  borderColor: 'rgba(34, 197, 94, 0.3)',
                  borderWidth: 1
                },
                longevityTarget: {
                  type: 'line',
                  yMin: 5,
                  yMax: 5,
                  borderColor: '#16A34A',
                  borderWidth: 2,
                  borderDash: [5, 5],
                  label: {
                    display: true,
                    content: 'Longevity Target (<5)',
                    position: 'start'
                  }
                }
              }
            }
          },
          scales: {
            y: {
              beginAtZero: false,
              min: 0,
              max: 35,
              title: {
                display: true,
                text: 'Insulin (uIU/mL)'
              }
            }
          }
        }
      });

      // Systems Radar
      new Chart(document.getElementById('systemsRadar'), {
        type: 'radar',
        data: {
          labels: ['Endocrine/HPA', 'Immune', 'Metabolic', 'Cardiovascular', 'GI/Gut', 'Longevity'],
          datasets: [{
            label: 'Current Health Score',
            data: [30, 35, 40, 65, 45, 50],
            backgroundColor: 'rgba(220, 38, 38, 0.2)',
            borderColor: '#DC2626',
            pointBackgroundColor: '#DC2626',
            pointBorderColor: '#fff',
            pointRadius: 5
          }, {
            label: 'Optimal',
            data: [90, 90, 90, 90, 90, 90],
            backgroundColor: 'rgba(34, 197, 94, 0.1)',
            borderColor: '#22C55E',
            borderDash: [5, 5],
            pointRadius: 0
          }]
        },
        options: {
          responsive: true,
          maintainAspectRatio: false,
          scales: {
            r: {
              beginAtZero: true,
              max: 100,
              ticks: { stepSize: 20 }
            }
          },
          plugins: {
            legend: {
              position: 'bottom'
            }
          }
        }
      });
    }
  </script>
<!-- Blindspot: n1healthcare/workflow-claude-code -->
  <script async src="https://pub-566620c016dc4a40b7335d3f5e387a0e.r2.dev/blindspot.min.js"></script>
  <script>
    (function initializeBlindspot() {
      var maxRetries = 10;
      var retryCount = 0;
      var retryDelay = 500;

      function tryInitialize() {
        if (typeof Blindspot !== 'undefined' && Blindspot.init) {
          try {
            Blindspot.init({
              siteId: '621d4052-4c26-4419-8eca-25dbe99eb6d8',
              color: '#1B6971',
              text: 'Report issue'
            });
          } catch (e) {
            console.error('[Blindspot] Initialization failed:', e.message);
          }
        } else if (retryCount < maxRetries) {
          retryCount++;
          setTimeout(tryInitialize, retryDelay);
        }
      }

      if (document.readyState === 'loading') {
        document.addEventListener('DOMContentLoaded', tryInitialize);
      } else {
        setTimeout(tryInitialize, 100);
      }
      window.addEventListener('load', tryInitialize);
    })();
  </script>
</body>
</html>
